ReP USP - Resultado da busca

Artigo de periodico
The effects of ketamine and classic hallucinogens on neurotrophic and inflammatory markers in unipolar treatment-resistant depression: a systematic review of clinical trials (2023)
Rossi, Giordano Novak; Hallak, Jaime Eduardo Cecilio ; Baker, Glen; Dursun, Serdar M.; Santos, Rafael Guimarães dos
Source: European Archives of Psychiatry and Clinical Neuroscience. Unidade: FMRP
Subjects: BIOMARCADORES, ANESTÉSICOS, ALUCINOGÊNICOS, DEPRESSÃO, ENSAIO CLÍNICO CONTROLADO RANDOMIZADO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ROSSI, Giordano Novak et al. The effects of ketamine and classic hallucinogens on neurotrophic and inflammatory markers in unipolar treatment-resistant depression: a systematic review of clinical trials. European Archives of Psychiatry and Clinical Neuroscience, v. 273, n. 1, p. 129-155, 2023Tradução . . Disponível em: https://doi.org/10.1007/s00406-022-01460-2. Acesso em: 09 nov. 2025.
APA
Rossi, G. N., Hallak, J. E. C., Baker, G., Dursun, S. M., & Santos, R. G. dos. (2023). The effects of ketamine and classic hallucinogens on neurotrophic and inflammatory markers in unipolar treatment-resistant depression: a systematic review of clinical trials. European Archives of Psychiatry and Clinical Neuroscience, 273( 1), 129-155. doi:10.1007/s00406-022-01460-2
NLM
Rossi GN, Hallak JEC, Baker G, Dursun SM, Santos RG dos. The effects of ketamine and classic hallucinogens on neurotrophic and inflammatory markers in unipolar treatment-resistant depression: a systematic review of clinical trials [Internet]. European Archives of Psychiatry and Clinical Neuroscience. 2023 ; 273( 1): 129-155.[citado 2025 nov. 09 ] Available from: https://doi.org/10.1007/s00406-022-01460-2
Vancouver
Rossi GN, Hallak JEC, Baker G, Dursun SM, Santos RG dos. The effects of ketamine and classic hallucinogens on neurotrophic and inflammatory markers in unipolar treatment-resistant depression: a systematic review of clinical trials [Internet]. European Archives of Psychiatry and Clinical Neuroscience. 2023 ; 273( 1): 129-155.[citado 2025 nov. 09 ] Available from: https://doi.org/10.1007/s00406-022-01460-2
Artigo de periodico-carta/editorial
Classical hallucinogens as antidepressant drugs [Editorial]: a cautionary approach (2023)
Santos, Rafael Guimarães dos ; Rossi, Giordano Novak; Hallak, Jaime Eduardo Cecilio ; Öngür, Dost; Dursun, Serdar M.
Source: Current Neuropharmacology. Unidade: FMRP
Subjects: ALUCINOGÊNICOS, ANTIDEPRESSIVOS, DEPRESSÃO, ANSIEDADE, ENSAIO CLÍNICO CONTROLADO RANDOMIZADO, EDITORIAL
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SANTOS, Rafael Guimarães dos et al. Classical hallucinogens as antidepressant drugs [Editorial]: a cautionary approach. Current Neuropharmacology. Sharjah: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.2174/1570159X20666220425133824. Acesso em: 09 nov. 2025. , 2023
APA
Santos, R. G. dos, Rossi, G. N., Hallak, J. E. C., Öngür, D., & Dursun, S. M. (2023). Classical hallucinogens as antidepressant drugs [Editorial]: a cautionary approach. Current Neuropharmacology. Sharjah: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. doi:10.2174/1570159X20666220425133824
NLM
Santos RG dos, Rossi GN, Hallak JEC, Öngür D, Dursun SM. Classical hallucinogens as antidepressant drugs [Editorial]: a cautionary approach [Internet]. Current Neuropharmacology. 2023 ; 21( 1): 10-12.[citado 2025 nov. 09 ] Available from: https://doi.org/10.2174/1570159X20666220425133824
Vancouver
Santos RG dos, Rossi GN, Hallak JEC, Öngür D, Dursun SM. Classical hallucinogens as antidepressant drugs [Editorial]: a cautionary approach [Internet]. Current Neuropharmacology. 2023 ; 21( 1): 10-12.[citado 2025 nov. 09 ] Available from: https://doi.org/10.2174/1570159X20666220425133824
Artigo de periodico
Molecular pathways of the therapeutic effects of Ayahuasca, a botanical psychedelic and potential rapid-acting antidepressant (2022)
Rossi, Giordano Novak; Guerra, Lorena Terene Lopes; Baker, Glen B.; Dursun, Serdar M.; Saiz, José Carlos Bouso; Hallak, Jaime Eduardo Cecilio ; Santos, Rafael Guimarães dos
Source: Biomolecules. Unidade: FMRP
Subjects: ALCALOIDES, ANTIDEPRESSIVOS, ALUCINOGÊNICOS, PLANTAS ALUCINÓGENAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ROSSI, Giordano Novak et al. Molecular pathways of the therapeutic effects of Ayahuasca, a botanical psychedelic and potential rapid-acting antidepressant. Biomolecules, v. 12, n. 11, p. 1-24, 2022Tradução . . Disponível em: https://doi.org/10.3390/biom12111618. Acesso em: 09 nov. 2025.
APA
Rossi, G. N., Guerra, L. T. L., Baker, G. B., Dursun, S. M., Saiz, J. C. B., Hallak, J. E. C., & Santos, R. G. dos. (2022). Molecular pathways of the therapeutic effects of Ayahuasca, a botanical psychedelic and potential rapid-acting antidepressant. Biomolecules, 12( 11), 1-24. doi:10.3390/biom12111618
NLM
Rossi GN, Guerra LTL, Baker GB, Dursun SM, Saiz JCB, Hallak JEC, Santos RG dos. Molecular pathways of the therapeutic effects of Ayahuasca, a botanical psychedelic and potential rapid-acting antidepressant [Internet]. Biomolecules. 2022 ; 12( 11): 1-24.[citado 2025 nov. 09 ] Available from: https://doi.org/10.3390/biom12111618
Vancouver
Rossi GN, Guerra LTL, Baker GB, Dursun SM, Saiz JCB, Hallak JEC, Santos RG dos. Molecular pathways of the therapeutic effects of Ayahuasca, a botanical psychedelic and potential rapid-acting antidepressant [Internet]. Biomolecules. 2022 ; 12( 11): 1-24.[citado 2025 nov. 09 ] Available from: https://doi.org/10.3390/biom12111618

USP Schools

ReP

Filtros

Authors

Subjects

Indexado em